Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1996 Sep 1;184(3):1149–1154. doi: 10.1084/jem.184.3.1149

A tumor-suppressor function for Fas (CD95) revealed in T cell-deficient mice

PMCID: PMC2192794  PMID: 9064331

Abstract

Fas (CD95) and its ligand are central regulatory molecules in hematopoietic cells. Previous studies have suggested a role for Fas in the regulation of tumor progression, but Fas has not yet been conclusively identified as a tumor suppressor. Fas-deficient individuals lack malignant tumors, perhaps because of regulation by T cells. To investigate such a possibility, mice deficient in both T cells and Fas were generated, and they were found to develop severe B cell dysregulation characterized by malignant, lethal B cell lymphoma. Lymphoma arose from a monoclonal B220+CD19-CD5-CD23- B cell secreting immunoglobulin M, kappa rheumatoid factor. In contrast, animals containing alpha beta T cells, gamma delta T cells, and/or functional Fas suppressed the development of lymphoma. These data indicate that Fas functions as a tumor suppressor, and identifies roles for both alpha beta T cells and gamma delta T cells in Fas-independent tumor regulation.

Full Text

The Full Text of this article is available as a PDF (3.8 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrews B. S., Eisenberg R. A., Theofilopoulos A. N., Izui S., Wilson C. B., McConahey P. J., Murphy E. D., Roths J. B., Dixon F. J. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med. 1978 Nov 1;148(5):1198–1215. doi: 10.1084/jem.148.5.1198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chiou S. K., Tseng C. C., Rao L., White E. Functional complementation of the adenovirus E1B 19-kilodalton protein with Bcl-2 in the inhibition of apoptosis in infected cells. J Virol. 1994 Oct;68(10):6553–6566. doi: 10.1128/jvi.68.10.6553-6566.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chu Y. W., Marin E., Fuleihan R., Ramesh N., Rosen F. S., Geha R. S., Insel R. A. Somatic mutation of human immunoglobulin V genes in the X-linked HyperIgM syndrome. J Clin Invest. 1995 Mar;95(3):1389–1393. doi: 10.1172/JCI117791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ferrone S., Marincola F. M. Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol Today. 1995 Oct;16(10):487–494. doi: 10.1016/0167-5699(95)80033-6. [DOI] [PubMed] [Google Scholar]
  5. Fisher G. H., Rosenberg F. J., Straus S. E., Dale J. K., Middleton L. A., Lin A. Y., Strober W., Lenardo M. J., Puck J. M. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell. 1995 Jun 16;81(6):935–946. doi: 10.1016/0092-8674(95)90013-6. [DOI] [PubMed] [Google Scholar]
  6. Gray I. C., Phillips S. M., Lee S. J., Neoptolemos J. P., Weissenbach J., Spurr N. K. Loss of the chromosomal region 10q23-25 in prostate cancer. Cancer Res. 1995 Nov 1;55(21):4800–4803. [PubMed] [Google Scholar]
  7. Herbst R. A., Weiss J., Ehnis A., Cavenee W. K., Arden K. C. Loss of heterozygosity for 10q22-10qter in malignant melanoma progression. Cancer Res. 1994 Jun 15;54(12):3111–3114. [PubMed] [Google Scholar]
  8. Hughes D. P., Hayday A., Craft J. E., Owen M. J., Crispe I. N. T cells with gamma/delta T cell receptors (TCR) of intestinal type are preferentially expanded in TCR-alpha-deficient lpr mice. J Exp Med. 1995 Jul 1;182(1):233–241. doi: 10.1084/jem.182.1.233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kondo E., Yoshino T., Yamadori I., Matsuo Y., Kawasaki N., Minowada J., Akagi T. Expression of Bcl-2 protein and Fas antigen in non-Hodgkin's lymphomas. Am J Pathol. 1994 Aug;145(2):330–337. [PMC free article] [PubMed] [Google Scholar]
  10. Lichter P., Walczak H., Weitz S., Behrmann I., Krammer P. H. The human APO-1 (APT) antigen maps to 10q23, a region that is syntenic with mouse chromosome 19. Genomics. 1992 Sep;14(1):179–180. doi: 10.1016/s0888-7543(05)80302-7. [DOI] [PubMed] [Google Scholar]
  11. Monroe J. G., Silberstein L. E. HIV-mediated B-lymphocyte activation and lymphomagenesis. J Clin Immunol. 1995 Mar;15(2):61–68. doi: 10.1007/BF01541733. [DOI] [PubMed] [Google Scholar]
  12. Morse H. C., 3rd, Davidson W. F., Yetter R. A., Murphy E. D., Roths J. B., Coffman R. L. Abnormalities induced by the mutant gene Ipr: expansion of a unique lymphocyte subset. J Immunol. 1982 Dec;129(6):2612–2615. [PubMed] [Google Scholar]
  13. Morse H. C., 3rd, Roths J. B., Davidson W. F., Langdon W. Y., Fredrickson T. N., Hartley J. W. Abnormalities induced by the mutant gene, lpr. Patterns of disease and expression of murine leukemia viruses in SJL/J mice homozygous and heterozygous for lpr. J Exp Med. 1985 Mar 1;161(3):602–616. doi: 10.1084/jem.161.3.602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Nagata S., Golstein P. The Fas death factor. Science. 1995 Mar 10;267(5203):1449–1456. doi: 10.1126/science.7533326. [DOI] [PubMed] [Google Scholar]
  15. Nussenzweig M. C., Schmidt E. V., Shaw A. C., Sinn E., Campos-Torres J., Mathey-Prevot B., Pattengale P. K., Leder P. A human immunoglobulin gene reduces the incidence of lymphomas in c-Myc-bearing transgenic mice. Nature. 1988 Dec 1;336(6198):446–450. doi: 10.1038/336446a0. [DOI] [PubMed] [Google Scholar]
  16. Peiffer S. L., Herzog T. J., Tribune D. J., Mutch D. G., Gersell D. J., Goodfellow P. J. Allelic loss of sequences from the long arm of chromosome 10 and replication errors in endometrial cancers. Cancer Res. 1995 May 1;55(9):1922–1926. [PubMed] [Google Scholar]
  17. Peng S. L., Madaio M. P., Hughes D. P., Crispe I. N., Owen M. J., Wen L., Hayday A. C., Craft J. Murine lupus in the absence of alpha beta T cells. J Immunol. 1996 May 15;156(10):4041–4049. [PubMed] [Google Scholar]
  18. Penninger J. M., Wen T., Timms E., Potter J., Wallace V. A., Matsuyama T., Ferrick D., Sydora B., Kronenberg M., Mak T. W. Spontaneous resistance to acute T-cell leukaemias in TCRV gamma 1.1J gamma 4C gamma 4 transgenic mice. Nature. 1995 May 18;375(6528):241–244. doi: 10.1038/375241a0. [DOI] [PubMed] [Google Scholar]
  19. Rathmell J. C., Cooke M. P., Ho W. Y., Grein J., Townsend S. E., Davis M. M., Goodnow C. C. CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells. Nature. 1995 Jul 13;376(6536):181–184. doi: 10.1038/376181a0. [DOI] [PubMed] [Google Scholar]
  20. Renno T., Hahne M., Tschopp J., MacDonald H. R. Peripheral T cells undergoing superantigen-induced apoptosis in vivo express B220 and upregulate Fas and Fas ligand. J Exp Med. 1996 Feb 1;183(2):431–437. doi: 10.1084/jem.183.2.431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Retter M. W., Eisenberg R. A., Cohen P. L., Clarke S. H. Sm and DNA binding by dual reactive B cells requires distinct VH, V kappa, and VH CDR3 structures. J Immunol. 1995 Aug 15;155(4):2248–2257. [PubMed] [Google Scholar]
  22. Roth C., Rochlitz C., Kourilsky P. Immune response against tumors. Adv Immunol. 1994;57:281–351. doi: 10.1016/s0065-2776(08)60675-6. [DOI] [PubMed] [Google Scholar]
  23. Rothstein T. L., Wang J. K., Panka D. J., Foote L. C., Wang Z., Stanger B., Cui H., Ju S. T., Marshak-Rothstein A. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature. 1995 Mar 9;374(6518):163–165. doi: 10.1038/374163a0. [DOI] [PubMed] [Google Scholar]
  24. Senju S., Negishi I., Motoyama N., Wang F., Nakayama K., Nakayama K., Lucas P. J., Hatakeyama S., Zhang Q., Yonehara S. Functional significance of the Fas molecule in naive lymphocytes. Int Immunol. 1996 Mar;8(3):423–431. doi: 10.1093/intimm/8.3.423. [DOI] [PubMed] [Google Scholar]
  25. Simon M., von Deimling A., Larson J. J., Wellenreuther R., Kaskel P., Waha A., Warnick R. E., Tew J. M., Jr, Menon A. G. Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression. Cancer Res. 1995 Oct 15;55(20):4696–4701. [PubMed] [Google Scholar]
  26. Singer G. G., Abbas A. K. The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity. 1994 Aug;1(5):365–371. doi: 10.1016/1074-7613(94)90067-1. [DOI] [PubMed] [Google Scholar]
  27. Speaks S. L., Sanger W. G., Masih A. S., Harrington D. S., Hess M., Armitage J. O. Recurrent abnormalities of chromosome bands 10q23-25 in non-Hodgkin's lymphoma. Genes Chromosomes Cancer. 1992 Oct;5(3):239–243. doi: 10.1002/gcc.2870050311. [DOI] [PubMed] [Google Scholar]
  28. Tamura T., Aoyama N., Saya H., Haga H., Futami S., Miyamoto M., Koh T., Ariyasu T., Tachi M., Kasuga M. Induction of Fas-mediated apoptosis in p53-transfected human colon carcinoma cells. Oncogene. 1995 Nov 16;11(10):1939–1946. [PubMed] [Google Scholar]
  29. Van Parijs L., Ibraghimov A., Abbas A. K. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity. 1996 Mar;4(3):321–328. doi: 10.1016/s1074-7613(00)80440-9. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES